))
Lung Cancer Edition: Top Headlines for Week of May 13, 2024
Manage episode 418412243 series 3560281
Healio에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Healio 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this edition, smoking cessation support uptake at lung cancer screenings, glecirasib may deliver ‘efficacy and tolerability advantages’ and more. Read the full coverage here:
Uptake of smoking cessation support high when offered at lung cancer screening
Glecirasib may deliver ‘efficacy and tolerability advantages’ for KRAS-mutant lung cancer
‘Substantial geographic disparities’ worsening in cancer clinical trial availability
Deployed military personnel have increased silica in lung tissue
FDA approves Alecensa for certain patients with ALK-positive lung cancer
References:
Lowers H, et al. Int J Environ Res Public Health. 2024;doi:10.3390/ijerph21010091.Press Release
Murray RL, et al. Eur Respir J. 2024;doi:10.1183/13993003.01768-2023.
Sekar RR, et al. JAMA Netw Open. 2024;doi:10.1001/jamanetworkopen.2024.10162.
Shi Y, et al. Abstract 468214. Presented at: ASCO Plenary Series; April 30, 2024.
118 에피소드
공유
